Switch in FGFR3 and -4 expression profile during human renal development may account for transient hypercalcemia in patients with Sotos syndrome due to 5q35 microdeletions

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 7, 2014, Pages

  Mutsaers, Henricus A M ^a,c   Levtchenko, Elena N ^d   Martinerie, Laetitia ^a,b   Pertijs, Jeanne C L M ^c   Allegaert, Karel ^d   Devriendt, Koenraad ^d   Masereeuw, Rosalinde ^c   Monnens, Leo A H ^c   Lombès, Marc ^a,b  

^a INSERM   (France)

^b Fondation PremUP   (France)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 4; KLOTHO PROTEIN; MESSENGER RNA;

ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FETUS; FETUS DEVELOPMENT; FGFR3 GENE; FGFR4 GENE; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GESTATIONAL AGE; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY DEVELOPMENT; KIDNEY PARENCHYMA; NEWBORN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOTOS SYNDROME; TRANSIENT INFANTILE HYPERCALCEMIA;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; FETUS; GENES, SWITCH; HUMANS; HYPERCALCEMIA; INFANT, NEWBORN; KIDNEY; MALE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; SOTOS SYNDROME; TRANSCRIPTOME;

EID: 84904040040     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1123     Document Type: Article

References (29)

1. Sotos JF, Dodge PR, Muirhead D, Crawford JD, Talbot NB. Cerebral gigantism in childhood. Asyndrome of excessively rapid growth and acromegalic features and a nonprogressive neurologic disorder. N Engl J Med. 1964;271:109-116.
2. Cole TR, Hughes HE. Sotos syndrome: a study of the diagnostic criteria and natural history. J Med Genet. 1994;31:20-32. (Pubitemid 24037942)
3. Tatton-Brown K, Rahman N. Sotos syndrome. Eur J Hum Genet. 2007;15:264-271.
4. Baujat G, Cormier-Daire V. Sotos syndrome. Orphanet J Rare Dis. 2007;2:36.
5. Tatton-Brown K, Douglas J, Coleman K, et al. Multiple mechanisms are implicated in the generation of 5q35 microdeletions in Sotos syndrome. J Med Genet. 2005;42:307-313. (Pubitemid 40523952)
6. Saugier-Veber P, Bonnet C, Drouin-Garraud V, et al. Heterogeneity of NSD1 alterations in 116 patients with Sotos syndrome. Hum Mutat. 2007;28:1098-1107. (Pubitemid 350036914)
7. Kenny J, Lees MM, Drury S, et al. Sotos syndrome, infantile hypercalcemia, and nephrocalcinosis: a contiguous gene syndrome. Pediatr Nephrol. 2011;26:1331-1334.
8. Magen D, Berger L, Coady MJ, et al. A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome. N Engl J Med. 2010;362:1102-1109.
9. Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H, Tenenhouse HS. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA. 1998;95:5372-5377. (Pubitemid 28208605)
10. Hu MC, Shiizaki K, Kuro-o M, Moe OW. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol. 2013;75:503-533.
11. Nabeshima Y. Discovery of α-Klotho unveiled new insights into calcium and phosphate homeostasis. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85:125-141.
12. Kurosu H, Ogawa Y, Miyoshi M, et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem. 2006;281:6120-6123. (Pubitemid 43847540)
13. Gattineni J, Bates C, Twombley K, et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. AmJ Physiol Renal Physiol. 2009;297:F282-F291.
14. Gattineni J, Twombley K, Goetz R, Mohammadi M, Baum M. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. Am J Physiol Renal Physiol. 2011;301:F371-F377.
15. Martinerie L, Viengchareun S, Delezoide AL, et al. Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates. Endocrinology. 2009;150:4414-4424.
16. Levtchenko E, Schoeber J, Jaeken J. Genetic disorders of renal phosphate transport. NEngl J Med. 2010;363:1774; author reply 1774-1775.
17. Gattineni J, Baum M. Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism. Pediatr Nephrol. 2010;25:591-601.
18. Tatton-Brown K, Douglas J, Coleman K, et al. Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet. 2005;77:193-204. (Pubitemid 41022703)
19. Shimada T, Kakitani M, Yamazaki Y, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitaminDmetabolism. J Clin Invest. 2004;113:561-568. (Pubitemid 38542505)
20. Yuan Q, Sitara D, Sato T, et al. PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels. Endocrinology. 2011;152:4053-4061.
21. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45-51. (Pubitemid 27494749)
22. Nakatani T, Sarraj B, Ohnishi M, et al. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23)-mediated regulation of systemic phosphate homeostasis. FASEB J. 2009;23:433-441.
23. Haenzi B, Bonny O, Masson R, et al. Loss of Memo, a novel FGFR regulator, results in reduced lifespan. FASEB J. 2014;28(1):327-336.
24. Cancilla B, Ford-Perriss MD, Bertram JF. Expression and localization of fibroblast growth factors and fibroblast growth factor receptors in the developing rat kidney. Kidney Int. 1999;56:2025-2039. (Pubitemid 30004731)
25. Ford MD, Cauchi J, Greferath U, Bertram JF. Expression of fibroblast growth factors and their receptors in rat glomeruli. Kidney Int. 1997;51:1729-1738. (Pubitemid 27252740)
26. Cool SM, Sayer RE, van Heumen WR, Pickles JO, Nurcombe V. Temporal and spatial expression of fibroblast growth factor receptor 4 isoforms in murine tissues. Histochem J. 2002;34:291-297. (Pubitemid 36543072)
27. Mangos S, Amaral AP, Faul C, Juppner H, Reiser J, Wolf M. Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio. Nephrol Dial Transplant. 2012;27:4314-4322.
28. Partanen J, Makela TP, Claesson-Welsh L, et al. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 1991;10:1347-1354. (Pubitemid 21905599)
29. Korhonen J, Partanen J, Alitalo K. Expression of FGFR-4 mRNA in developing mouse tissues. Int J Dev Biol. 1992;36:323-329.